Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gel

BACKGROUND: In a recent placebo-controlled Phase III study, oxybutynin chloride topical gel (OTG) significantly improved urinary continence in patients with overactive bladder. In this post hoc analysis, the effect of incontinence severity on OTG-mediated improvement in continence was evaluated. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Sand, Peter K, MacDiarmid, Scott A, Thomas, Heather, Caramelli, Kim E, Hoel, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818944/
https://www.ncbi.nlm.nih.gov/pubmed/24198648
http://dx.doi.org/10.2147/OAJU.S24199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818944/
https://www.ncbi.nlm.nih.gov/pubmed/24198648
http://dx.doi.org/10.2147/OAJU.S24199

Ejemplares similares